Gossamer Bio Inc (GOSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -170,370 | -56,528 | -179,817 | -229,378 | -234,004 |
| Depreciation Amortization | -5,291 | -7,825 | -3,744 | 4,187 | 12,237 |
| Accounts payable and accrued liabilities | -2,747 | -1,656 | 3,990 | -1,813 | -4,428 |
| Other Working Capital | -12,669 | 42,846 | -11,859 | -1,738 | 4,354 |
| Other Operating Activity | 19,811 | 19,695 | 32,272 | 41,710 | 32,951 |
| Operating Cash Flow | $-171,266 | $-3,468 | $-159,158 | $-187,032 | $-188,890 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 149,293 | 29,023 | -110,970 | -560 | -115,806 |
| PPE Investments | -79 | N/A | N/A | -410 | -1,546 |
| Sale Of Investment | 7,144 | 0 | 0 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -65 | -75 |
| Investing Cash Flow | $156,358 | $29,023 | $-110,970 | $-1,035 | $-117,427 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 0 | -12,581 | -11,613 | -5,806 | 0 |
| Common Stock Issued | 6,425 | 629 | 201,767 | 122,896 | 3,329 |
| Other Financing Activity | 0 | 464 | 0 | 0 | 0 |
| Financing Cash Flow | $6,425 | $-11,488 | $190,154 | $117,090 | $3,329 |
| Exchange Rate Effect | 141 | -102 | 110 | -517 | -165 |
| Beginning Cash Position | 46,074 | 32,109 | 111,973 | 183,467 | 486,620 |
| End Cash Position | 37,732 | 46,074 | 32,109 | 111,973 | 183,467 |
| Net Cash Flow | $-8,342 | $13,965 | $-79,864 | $-71,494 | $-303,153 |
| Free Cash Flow | |||||
| Operating Cash Flow | -171,266 | -3,468 | -159,158 | -187,032 | -188,890 |
| Capital Expenditure | -79 | 0 | 0 | -410 | -1,546 |
| Free Cash Flow | -171,345 | -3,468 | -159,158 | -187,442 | -190,436 |